Literature DB >> 8622556

Phosphorylation of enkephalins enhances their proteolytic stability.

C Dass1, P Mahalakshmi.   

Abstract

Pharmacological action of enkephalins as opioid peptides is limited because of their rapid degradation by endoproteases. A novel approach is used in this study to prolong the life of those peptides. Phosphorylation of N-terminal tyrosine residue is found to have a profound influence in improving the stability of [Met]enkephalin and [Leu]enkephalin against the action of aminopeptidase M. Whereas, breakdown of [Met]enkephalin and [Leu]enkephalin is essentially complete in less than one min when incubated at 37 degree C with purified aminopeptidase M (EC3.4.11.2; substrate:enzyme = 1:0.1) in Tris buffer (pH 7.02), the corresponding phospho analogs are still detected 60 min after start of incubation. The rate of disappearance of phospho-[Met]enkephalin and phospho-[Leu]enkephalin follows first-order kinetics with half-lives of 7.3 and 8.3 min, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622556     DOI: 10.1016/0024-3205(96)00057-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Phosphorylation of enkephalins: NMR and CD studies in aqueous and membrane-mimicking environments.

Authors:  Larisa Yeomans; Dhanasekaran Muthu; John J Lowery; Heather N Martinez; Leif Abrell; Guanxin Lin; Kyle Strom; Brian I Knapp; Jean M Bidlack; Edward J Bilsky; Robin Polt
Journal:  Chem Biol Drug Des       Date:  2011-09-26       Impact factor: 2.817

2.  The effect of N-terminal acetylation and the inhibition activity of acetylated enkephalins on the aminopeptidase M-catalyzed hydrolysis of enkephalins.

Authors:  D S Jayawardene; C Dass
Journal:  Peptides       Date:  1999       Impact factor: 3.750

3.  An Effective and Safe Enkephalin Analog for Antinociception.

Authors:  K K DurgaRao Viswanadham; Roland Böttger; Lukas Hohenwarter; Anne Nguyen; Elham Rouhollahi; Alexander Smith; Yi-Hsuan Tsai; Yuan-Yu Chang; Christopher Llynard Ortiz; Lee-Wei Yang; Liliana Jimenez; Siyuan Li; Chan Hur; Shyh-Dar Li
Journal:  Pharmaceutics       Date:  2021-06-22       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.